VKTX Viking Therapeutics, Inc. - Common Stock
$34.54
价格 · 八月 19, 2026
截至...的财报数据 七月 29, 2026
52周区间
$23–$43
57% of range
分析师评级
BUY
26 analysts
目标价
$92
+168% upside
P/E (TTM)
-10.8
ROE
-47.3%
净利润率
—
VKTX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$34.54
市值
$3.96B
P/E (TTM)
-10.8
每股收益 (TTM)
$-3.19
营收 (TTM)
$0
股息收益率
—
ROE
-47.3%
负债/权益
—
52周区间
$23 – $43
VKTX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2016-12-31
→
2025-12-31
EPS
$-3.19
2021-12-31
→
2025-12-31
自由现金流
—
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
VKTX
同行中位数
P/E (TTM)
-10.8
13.2
P/B (市净率)
6.2
3.5
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
VKTX
同行中位数
ROA
-44.3%
-42.2%
ROE
-47.3%
-52.8%
ROIC
-61.6%
—
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
VKTX
同行中位数
Current Ratio (流动比率)
9.3
10.3
Quick Ratio (速动比率)
2.2
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
VKTX
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
VKTX
同行中位数
VKTX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
26 位分析师
- 强烈买入 9 34.6%
- 买入 14 53.8%
- 持有 3 11.5%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
19 位分析师 · 2026-08-19
中位数
$95.00
← 低于所有目标
$34.54
最低
$35.00
最高
$125.00
中位数目标
$95.00
+175.0%
平均目标
$92.39
+167.5%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-0.16%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-1.10 | $-1.27 | 0.17% |
| 2026年3月31日 | $-1.37 | $-1.03 | -0.34% |
| 2025年12月31日 | $-1.38 | $-0.91 | -0.47% |
| 2025年9月30日 | $-0.81 | $-0.69 | -0.12% |
| 2025年6月30日 | $-0.58 | $-0.46 | -0.12% |
| 2025年3月31日 | $-0.41 | $-0.33 | -0.08% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| VKTX | $4.04B | -11.0 | — | — | -47.3% | — |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | — |
| LEGN | — | — | — | — | — | — |
| DNLI | $2.58B | -5.6 | 204.7% | — | -50.2% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $345M | $102M | $64M | $54M | $45M | $32M | $24M | $19M | $14M | $9M | $7M | $22M | |
| SG&A Expense | $48M | $49M | $37M | $16M | $11M | $11M | $9M | $7M | $5M | $5M | $5M | $1M | |
| Operating Expenses | $393M | $151M | $101M | $70M | $56M | $43M | $33M | $26M | $19M | $14M | $12M | $23M | |
| Operating Income | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | $-23M | |
| Other Non-op | $34M | $41M | $15M | $1M | $692.0K | $3M | $7M | $4M | $-2M | $-884.5K | $-11M | $2M | |
| Pretax Income | $-360M | $-110M | $-86M | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.0K | $1.0K | $1.0K | $1.0K | $2.0K | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | $-22M | |
| EPS (Basic) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 | · | · | · | · | · | · | · | |
| Shares (Basic) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 112,667,000 | 109,037,000 | 94,347,000 | 76,834,000 | 77,198,000 | · | · | · | · | · | · | · | |
| EBITDA | $-393M | $-151M | $-101M | $-70M | $-56M | $-43M | $-33M | $-26M | $-19M | $-14M | $-12M | · |
资产负债表 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $27M | $56M | $37M | $26M | $29M | $8M | $25M | $9M | $3M | $768.5K | $755.9K | |
| Short-term Investments | · | · | · | · | · | $219M | $267M | $277M | $12M | $10M | $13M | · | |
| Prepaid Expense | $2M | $1M | $3M | $3M | $619.0K | $442.0K | $405.0K | $278.0K | $389.0K | $282.7K | $1M | $17.8K | |
| Current Assets | $716M | $907M | $367M | $167M | $211M | $256M | $284M | $302M | $22M | $14M | $15M | $773.7K | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $775 | |
| Total Assets | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Accounts Payable | $53M | $10M | $8M | $9M | $1M | $4M | $2M | $959.0K | $2M | $1M | $592.4K | $2M | |
| Current Liabilities | $77M | $27M | $19M | $22M | $9M | $12M | $7M | $5M | $9M | $6M | $2M | $23M | |
| Capital Leases | $0 | $630.0K | $936.0K | $1M | · | $29.0K | $360.0K | · | · | · | · | · | |
| Total Liabilities | $77M | $28M | $20M | $23M | $9M | $12M | $7M | $5M | $9M | $6M | $7M | $25M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $358 | $208 | $97 | $60 | |
| Retained Earnings | $-848M | $-488M | $-378M | $-292M | $-223M | $-168M | $-129M | $-103M | $-81M | $-60M | $-46M | $-22M | |
| Treasury Stock | $0 | $0 | $7M | $7M | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $639M | $880M | $348M | $145M | $202M | $244M | $277M | $298M | $13M | $8M | $9M | $-22M | |
| Liabilities + Equity | $716M | $908M | $368M | $169M | $211M | $257M | $284M | $302M | $22M | $15M | $15M | $3M | |
| Shares Outstanding | 114,793,067 | 111,573,519 | 100,113,770 | 78,257,258 | 78,248,401 | 73,215,940 | 72,413,602 | 71,742,043 | 35,817,104 | 20,823,873 | 9,683,741 | 6,000,000 |
现金流 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $30M | $17M | $9M | $6M | $6M | $4M | $3M | $1M | $2M | $3M | $6.3K | |
| Operating Cash Flow | $-279M | $-88M | $-73M | $-48M | $-48M | $-22M | $-25M | $-19M | $-15M | $-11M | $-9M | $-2M | |
| Investing Cash Flow | $341M | $-553M | $-179M | $55M | $38M | $42M | $7M | $-266M | $-2M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $297M | $22M | $12M | $25M | · | |
| Stock Repurchased | · | · | · | $7M | · | · | · | · | · | $229 | $38 | $2 | |
| Net Stock Activity | · | · | · | $-7M | · | · | · | $297M | $22M | $12M | $25M | · | |
| Financing Cash Flow | $76M | $612M | $271M | $4M | $7M | $950.0K | $887.0K | $300M | $22M | · | · | · | |
| Net Change in Cash | · | · | · | $11M | $-3M | $21M | $-16M | $16M | $6M | $2M | $12.7K | $576.2K |
盈利能力 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -44.3% | -17.2% | -32.0% | -36.3% | -23.5% | -14.6% | -8.8% | -13.6% | -112.3% | -98.3% | -253.3% | · | |
| ROE | -47.3% | -17.9% | -34.8% | -39.7% | -24.6% | -15.2% | -9.0% | -14.2% | -191.3% | -175.7% | 349.2% | · | |
| ROIC | -61.6% | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 | 21.1 | 41.8 | 66.4 | 2.5 | 2.2 | 7.7 | · | |
| Quick Ratio | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 | 20.5 | 40.7 | 66.3 | 2.4 | 2.0 | 7.1 | · |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | |
| Net Income TTM | $-360M | $-110M | $-86M | $-69M | $-55M | $-39M | $-26M | $-22M | $-21M | $-15M | $-23M | · | |
| Market Cap | $4.04B | $4.49B | $1.86B | $736M | $360M | $412M | $581M | $549M | $145M | $25M | $33M | · | |
| P/E | -11.0 | -39.8 | -20.5 | -10.4 | -6.5 | · | · | · | · | · | · | · | |
| P/B | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | 2.1 | 1.8 | 10.8 | 3.1 | 3.8 | · | |
| P / Tangible Book | 6.3 | 5.1 | 5.3 | 5.1 | 1.8 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -14.5 | -51.1 | -25.4 | -15.2 | -7.6 | -18.9 | -23.5 | -29.3 | -9.9 | -2.2 | -3.8 | · | |
| Earnings Yield | -9.1% | -2.5% | -4.9% | -9.6% | -15.4% | · | · | · | · | · | · | · |
损益表 12
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $116M | $150M | $153M | $90M | $60M | $41M | $31M | $23M | $24M | $24M | $18M | $14M | $11M | $12M | $14M | $13M | |
| SG&A Expense | $17M | $14M | $11M | $9M | $14M | $14M | $15M | $14M | $10M | $10M | $9M | $10M | $10M | $4M | $4M | $4M | |
| Operating Expenses | $133M | $164M | $165M | $99M | $75M | $55M | $46M | $37M | $34M | $34M | $27M | $24M | $21M | $16M | $18M | $16M | |
| Operating Income | $-133M | $-164M | $-165M | $-99M | $-75M | $-55M | $-46M | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M | |
| Other Non-op | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $12M | $7M | $5M | $5M | $1M | $423.0K | $199.0K | $142.0K | |
| Net Income | $-128M | $-158M | $-158M | $-91M | $-66M | $-46M | $-35M | $-25M | $-22M | $-27M | $-23M | $-19M | $-20M | $-16M | $-17M | $-16M | |
| EPS (Basic) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| EPS (Diluted) | $-1.10 | $-1.37 | $-1.39 | $-0.81 | $-0.58 | $-0.41 | $-0.33 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | |
| Shares (Basic) | 116,263,000 | 115,568,000 | -223,856,000 | 112,320,000 | 112,134,000 | 112,069,000 | -215,721,000 | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| Shares (Diluted) | 116,263,000 | 115,568,000 | -223,856,000 | 112,320,000 | 112,134,000 | 112,069,000 | -215,721,000 | 110,911,000 | 110,390,000 | 103,457,000 | 99,846,000 | 99,010,000 | 78,352,000 | 76,505,000 | 76,842,000 | 77,413,000 | |
| EBITDA | $-133M | $-164M | · | $-99M | $-75M | $-55M | · | $-37M | $-34M | $-34M | $-27M | $-24M | $-21M | $-16M | $-18M | $-16M |
资产负债表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $118M | $166M | $100M | $34M | $38M | $27M | $50M | $44M | $196M | $37M | $70M | $18M | $29M | $16M | $12M | |
| Prepaid Expense | $941.0K | $1M | $2M | $2M | $3M | $865.0K | $1M | $2M | $138.0K | $643.0K | $670.0K | $960.0K | $4M | $956.0K | $1M | $388.0K | |
| Current Assets | $518M | $608M | $716M | $739M | $827M | $866M | $907M | $937M | $946M | $966M | $381M | $399M | $149M | $165M | $180M | $193M | |
| Total Assets | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Accounts Payable | $69M | $67M | $53M | $4M | $5M | $8M | $10M | $254.0K | $11M | $5M | $6M | $6M | $4M | $3M | $6M | $3M | |
| Current Liabilities | $110M | $106M | $77M | $26M | $32M | $20M | $27M | $26M | $25M | $33M | $13M | $13M | $16M | $14M | $15M | $11M | |
| Capital Leases | $4M | $0 | $0 | $318.0K | $410.0K | $502.0K | $630.0K | $755.0K | $766.0K | $852.0K | $1M | $1M | $1M | $1M | $1M | $1M | |
| Total Liabilities | $114M | $106M | $77M | $26M | $32M | $20M | $28M | $26M | $26M | $34M | $14M | $15M | $17M | $15M | $16M | $13M | |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Retained Earnings | $-1.13B | $-1.01B | $-848M | $-690M | $-599M | $-534M | $-488M | $-452M | $-428M | $-405M | $-353M | $-331M | $-312M | $-272M | $-257M | $-239M | |
| Treasury Stock | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7M | $7M | $7M | $7M | $7M | $5M | |
| Stockholders' Equity | $408M | $502M | $639M | $713M | $795M | $847M | $880M | $911M | $921M | $934M | $368M | $386M | $134M | $151M | $165M | $182M | |
| Liabilities + Equity | $522M | $608M | $716M | $739M | $828M | $867M | $908M | $938M | $947M | $968M | $383M | $401M | $151M | $167M | $182M | $195M | |
| Shares Outstanding | 116,652,937 | 115,893,943 | 114,793,067 | 112,446,961 | 112,329,709 | 112,288,759 | 111,573,519 | 111,434,821 | 110,796,200 | 110,228,869 | 100,028,828 | 100,028,828 | 79,319,081 | 76,688,478 | 76,688,478 | 77,373,712 |
现金流 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $11M | $10M | $9M | $7M | $14M | $11M | $6M | $9M | $7M | $8M | $4M | $5M | $4M | $2M | $2M | $2M | |
| Operating Cash Flow | $-125M | $-114M | $-85M | $-94M | $-47M | $-52M | $-31M | $-22M | $-29M | $-6M | $-20M | $-11M | $-25M | $-13M | $-13M | $-11M | |
| Investing Cash Flow | $109M | $54M | $76M | $160M | $43M | $63M | $7M | $26M | $-126M | $-460M | $-13M | $-204M | $2M | $27M | $19M | $2M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $2M | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-5M | |
| Financing Cash Flow | $24M | $12M | $75M | $480.0K | $507.0K | $349.0K | $1M | $3M | $3M | $606M | $-74.0K | $267M | $4M | $10.0K | $-2M | $-5M | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $51M | $-18M | $13M | $4M | $-14M |
盈利能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.0% | -21.5% | · | -10.8% | -7.4% | -5.0% | · | -3.8% | -3.3% | -4.9% | -8.2% | -6.6% | -11.3% | -8.1% | -8.3% | -7.2% | |
| ROE | -21.3% | -23.5% | · | -11.2% | -7.6% | -5.1% | · | -3.9% | -3.4% | -5.1% | -8.7% | -7.0% | -12.3% | -8.7% | -8.9% | -7.7% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 5.7 | · | 28.3 | 25.9 | 44.2 | · | 36.5 | 37.7 | 29.5 | 28.4 | 29.6 | 9.6 | 11.7 | 12.1 | 17.2 | |
| Quick Ratio | 1.1 | 1.1 | · | 3.9 | 1.1 | 1.9 | · | 2.0 | 1.8 | 6.0 | 2.8 | 5.2 | 1.2 | 2.1 | 1.1 | 1.1 |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
估值 (TTM) 8
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-443M | $-360M | · | $-227M | $-158M | $-120M | · | $-97M | $-91M | $-89M | $-77M | $-72M | $-69M | $-63M | $-62M | $-59M | |
| Market Cap | $4.55B | $3.77B | · | $2.96B | $2.98B | $2.71B | · | $7.05B | $5.87B | $9.04B | $1.11B | $1.62B | $1.32B | $209M | $222M | $232M | |
| P/E | -10.1 | -10.3 | · | -13.0 | -18.8 | -22.2 | · | -69.6 | -60.2 | -88.2 | -12.6 | -18.4 | -18.5 | -3.3 | -3.6 | · | |
| P/B | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Tangible Book | 11.1 | 7.5 | · | 4.1 | 3.7 | 3.2 | · | 7.7 | 6.4 | 9.7 | 3.0 | 4.2 | 9.9 | 1.4 | 1.3 | 1.3 | |
| P / Cash Flow | · | -33.1 | · | · | · | -51.8 | · | · | · | -1473.6 | · | · | -53.6 | · | · | -22.0 | |
| Earnings Yield | -9.9% | -9.7% | · | -7.7% | -5.3% | -4.5% | · | -1.4% | -1.7% | -1.1% | -8.0% | -5.4% | -5.4% | -30.1% | -28.0% | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $0 | $0 | $0 | $0 | $0 |
| 净收入 | $-360M | $-110M | $-86M | $-69M | $-55M |
| 稀释后每股收益 (EPS) | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 流动比率 | 9.3 | 33.1 | 19.2 | 7.6 | 24.0 |
| 速动比率 | 2.2 | 1.0 | 2.9 | 1.7 | 3.0 |
最新新闻 提及该公司的近期头条新闻
- 2 Beaten-Down Stocks With Massive Upside Potential
- Is Viking Therapeutics Stock a No-Brainer Buy Below $35?
- Is Viking Therapeutics Stock Going to $100?
- Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%
- 1 导致这家生物科技公司在年末前可能飙升三倍的原因
- 你有 $1,500 吗？是买 比特币，还是 Viking Therapeutics 更好？
- 关于这家刚刚获得 700 万美元新投资的肥胖药物开发商，您需要了解什么
交易信号 近期买入/卖出信号，包含入场价和风险/回报比
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 503 家申报者 · $2.6B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 92 (+17 与上一季度对比) | 44 (-24 与上一季度对比) | 140 (-21 与上一季度对比) | 127 (+6 与上一季度对比) | +4.1M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| STATE STREET CORP | $218705430 | 5606394 | 8.30% | 股份 |
| FMR LLC | $197202455 | 5055177 | 7.49% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $197143394 | 5053663 | 7.49% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $174931100 | 4484263 | 6.64% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $153598520 | 3937414 | 5.83% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $113382565 | 2906500 | 4.31% | 买入期权 |
| TWO SIGMA ADVISERS, LP | $74906241 | 2129228 | 2.84% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $70844186 | 1816050 | 2.69% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $69510737 | 1781277 | 2.64% | 股份 |
| D. E. Shaw & Co., Inc. | $62649826 | 1605994 | 2.38% | 股份 |
| DIADEMA PARTNERS LP | $47623408 | 1220800 | 1.81% | 买入期权 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $46039602 | 1180200 | 1.75% | 卖出期权 |
| CITADEL ADVISORS LLC | $43773121 | 1122100 | 1.66% | 买入期权 |
| BNP PARIBAS FINANCIAL MARKETS | $38296117 | 981700 | 1.45% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $31846477 | 816367 | 1.21% | 股份 |
| GOLDMAN SACHS GROUP INC | $30821099 | 790082 | 1.17% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $28557153 | 732047 | 1.08% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $28504217 | 730690 | 1.08% | 股份 |
| Pictet Asset Management Holding SA | $26640280 | 682909 | 1.01% | 股份 |
| Vestal Point Capital, LP | $26526800 | 680000 | 1.01% | 股份 |
| AMERIPRISE FINANCIAL INC | $24858186 | 637226 | 0.94% | 股份 |
| CITADEL ADVISORS LLC | $23530832 | 603200 | 0.89% | 卖出期权 |
| Eversept Partners, LP | $23519987 | 602922 | 0.89% | 股份 |
| BlackBarn Capital Partners LP | $23406000 | 600000 | 0.89% | 股份 |
| JANE STREET GROUP, LLC | $22996200 | 589495 | 0.87% | 股份 |
| ADAR1 Capital Management, LLC | $22393222 | 574038 | 0.85% | 股份 |
| JANE STREET GROUP, LLC | $20870350 | 535000 | 0.79% | 买入期权 |
| DIMENSIONAL FUND ADVISORS LP | $20787961 | 532888 | 0.79% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $20698979 | 530607 | 0.79% | 股份 |
| Caption Management, LLC | $20511458 | 525800 | 0.78% | 买入期权 |
| TANG CAPITAL MANAGEMENT LLC | $19505000 | 500000 | 0.74% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $19433690 | 498172 | 0.74% | 股份 |
| Point72 Asset Management, L.P. | $18463745 | 473308 | 0.70% | 股份 |
| Clearbridge Investments, LLC | $17350907 | 444781 | 0.66% | 股份 |
| DIADEMA PARTNERS LP | $17234930 | 441808 | 0.65% | 股份 |
| BLAIR WILLIAM & CO/IL | $16258035 | 416766 | 0.62% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $15513614 | 397683 | 0.59% | 股份 |
| BlackRock, Inc. | $15432395 | 395601 | 0.59% | 股份 |
| ExodusPoint Capital Management, LP | $15346650 | 393000 | 0.58% | 买入期权 |
| Walleye Trading LLC | $14964236 | 383600 | 0.57% | 买入期权 |
| First Washington CORP | $14874513 | 381300 | 0.56% | 股份 |
| ExodusPoint Capital Management, LP | $14087525 | 361126 | 0.53% | 股份 |
| Steward Partners Investment Advisory, LLC | $13699454 | 351178 | 0.52% | 股份 |
| DIADEMA PARTNERS LP | $13673005 | 350500 | 0.52% | 卖出期权 |
| JANE STREET GROUP, LLC | $12955221 | 332100 | 0.49% | 卖出期权 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $12877000 | 330100 | 0.49% | 股份 |
| Woodline Partners LP | $11810317 | 302751 | 0.45% | 股份 |
| GROUP ONE TRADING LLC | $10198891 | 261443 | 0.39% | 股份 |
| WASATCH ADVISORS LP | $10190161 | 313158 | 0.39% | 股份 |
| PFM Health Sciences, LP | $9960423 | 255330 | 0.38% | 股份 |
| BlackBarn Capital Partners LP | $9752500 | 250000 | 0.37% | 买入期权 |
| Gotham Asset Management, LLC | $9001050 | 230737 | 0.34% | 股份 |
| BANK OF AMERICA CORP /DE/ | $8875595 | 227521 | 0.34% | 股份 |
| Swiss National Bank | $8617309 | 220900 | 0.33% | 股份 |
| Nuveen Asset Management, LLC | $8168680 | 202999 | 0.31% | 股份 |
| ACT CAPITAL MANAGEMENT, LLC | $8164793 | 209300 | 0.31% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $7833596 | 200810 | 0.30% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $7697882 | 197331 | 0.29% | 股份 |
| Cetera Investment Advisers | $7199003 | 184543 | 0.27% | 股份 |
| WOLVERINE TRADING, LLC | $7128722 | 276200 | 0.27% | 买入期权 |
| Artia Global Partners LP | $7050316 | 180731 | 0.27% | 股份 |
| LPL Financial LLC | $6377862 | 163493 | 0.24% | 股份 |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $6072375 | 155662 | 0.23% | 股份 |
| Granahan Investment Management, LLC | $5775196 | 148044 | 0.22% | 股份 |
| OPPENHEIMER & CO INC | $5705564 | 146259 | 0.22% | 股份 |
| RFG Advisory, LLC | $5570234 | 142790 | 0.21% | 股份 |
| UBS Group AG | $5212672 | 133624 | 0.20% | 股份 |
| Rhenman & Partners Asset Management AB | $4993280 | 128000 | 0.19% | 股份 |
| Balyasny Asset Management L.P. | $4521493 | 115906 | 0.17% | 股份 |
| RHUMBLINE ADVISERS | $4455330 | 114211 | 0.17% | 股份 |
| FIRST TRUST ADVISORS LP | $4437402 | 113751 | 0.17% | 股份 |
| Persistent Asset Partners Ltd | $4397831 | 112736 | 0.17% | 股份 |
| Trexquant Investment LP | $4388586 | 112499 | 0.17% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $4273936 | 109560 | 0.16% | 股份 |
| Institute for Wealth Management, LLC. | $4238164 | 108643 | 0.16% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4049668 | 124452 | 0.15% | 股份 |
| Caption Management, LLC | $4006327 | 102700 | 0.15% | 卖出期权 |
| Rafferty Asset Management, LLC | $3880520 | 99475 | 0.15% | 股份 |
| Quantum Private Wealth, LLC | $3837238 | 98365 | 0.15% | 股份 |
| Man Group plc | $3718979 | 95334 | 0.14% | 股份 |
| LBP AM SA | $3663273 | 93906 | 0.14% | 股份 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $3642910 | 93384 | 0.14% | 股份 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $3574642 | 91634 | 0.14% | 股份 |
| AXQ CAPITAL, LP | $3566957 | 91437 | 0.14% | 股份 |
| WINTON GROUP Ltd | $3532199 | 90546 | 0.13% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $3510900 | 90000 | 0.13% | 买入期权 |
| Bridgewater Associates, LP | $3427380 | 87859 | 0.13% | 股份 |
| VANGUARD GROUP INC | $3364967 | 95650 | 0.13% | 股份 |
| Cornerstone Capital, Inc. | $3334185 | 85470 | 0.13% | 股份 |
| EXCHANGE TRADED CONCEPTS, LLC | $3167066 | 81186 | 0.12% | 股份 |
| 683 Capital Management, LLC | $3120800 | 80000 | 0.12% | 买入期权 |
| CAPITAL FUND MANAGEMENT S.A. | $2934176 | 75216 | 0.11% | 股份 |
| Odyssean, LLC | $2925243 | 74987 | 0.11% | 股份 |
| D. E. Shaw & Co., Inc. | $2921849 | 74900 | 0.11% | 买入期权 |
| Y-Intercept (Hong Kong) Ltd | $2825884 | 72440 | 0.11% | 股份 |
| WOLVERINE TRADING, LLC | $2813290 | 109000 | 0.11% | 卖出期权 |
| Lewis Asset Management, LLC | $2605478 | 66790 | 0.10% | 股份 |
| Summit Financial, LLC | $2605301 | 66785 | 0.10% | 股份 |
| CITADEL ADVISORS LLC | $2599743 | 66643 | 0.10% | 股份 |
| MONIMUS CAPITAL MANAGEMENT, LP | $2594243 | 66502 | 0.10% | 股份 |
公司内部人士 16 位内幕人士 · 9 位高管 · 7 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Brian Lian | President & CEO | 2026年7月29日 S | 2572441 | 0 | 6 | $-14005897 |
| Greg Zante | Chief Financial Officer | 2026年7月29日 S | 212204 | 0 | 6 | $-2823737 |
| Marianna Mancini | Chief Operating Officer | 2026年7月29日 S | 422760 | 0 | 6 | $-2727473 |
| Michael Dinerman | Chief Operating Officer | 2015年5月4日 C | 694116 | 0 | 0 | $0 |
| Hubert C Chen | Chief Medical Officer | 2026年6月1日 A | — | 0 | 0 | $0 |
| Neil William Aubuchon | Chief Commercial Officer | 2026年3月10日 P | 4475 | 1 | 0 | $149912 |
| Michael Morneau | VP, Finance and Administration | 2021年1月19日 F | 116062 | 0 | 0 | $0 |
| Hiroko Masamune | Chief Development Officer | 2019年1月3日 A | 141063 | 0 | 0 | $0 |
| Rochelle Hanley | Chief Medical Officer | 2016年5月4日 F | 160836 | 0 | 0 | $0 |
| Sarah Kathryn Rouan | 董事 | 2026年1月2日 A | 4390 | 0 | 0 | $0 |
| Lawson Macartney | 董事 | 2026年1月2日 A | 51115 | 0 | 0 | $0 |
| Charles A Rowland Jr | 董事 | 2026年1月2日 A | 33150 | 0 | 1 | $-2134200 |
| Matthew J Singleton | 董事 | 2026年1月2日 A | 12650 | 0 | 0 | $0 |
| Matthew W Foehr | 董事 | 2026年1月2日 A | 135186 | 0 | 1 | $-561760 |
| Stephen W Webster | 董事 | 2020年1月2日 A | 8000 | 0 | 0 | $0 |
| Dorothy Elizabeth Kelly-Gemmell | — | 2026年8月1日 A | 6333 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 58 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 2.41% | 119108 NS | 2026年5月31日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.82% | 135757 NS | 2026年4月30日 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 0.75% | 22931 NS | 2026年5月31日 | N-PORT |
| BBC · ETFis Series Trust I | 0.62% | 7443 NS | 2026年4月30日 | N-PORT |
| HRTS · Tema ETF Trust | 0.54% | 8538 NS | 2026年5月31日 | N-PORT |
| EVNT · AltShares Trust | 0.53% | 2000 NS | 2026年5月31日 | N-PORT |
| FMED · Fidelity Covington Trust | 0.43% | 5422 NS | 2026年5月31日 | N-PORT |
| FXH · First Trust Exchange-Traded Alpha... | 0.39% | 109034 NS | 2026年4月30日 | N-PORT |
| ESSC · Strategy Shares | 0.31% | 2593 NS | 2026年4月30日 | N-PORT |
| TMFX · RBB Fund, Inc. | 0.19% | 1854 NS | 2026年5月31日 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0.15% | 3856 NS | 2026年4月30日 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.08% | 555687 NS | 2026年5月31日 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund ... | 0.07% | 42871 NS | 2026年4月30日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.05% | 49795 NS | 2026年4月30日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.02% | 4353 NS | 2026年5月31日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.02% | 56 NS | 2026年5月31日 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 48308 NS | 2026年4月30日 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0.01% | 35206 NS | 2026年5月31日 | N-PORT |
| GVUS · Goldman Sachs ETF Trust | 0.01% | 1208 NS | 2026年5月31日 | N-PORT |
| REVS · Columbia ETF Trust I | 0.01% | 791 NS | 2026年4月30日 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 3542 NS | 2026年4月30日 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.01% | 71527 NS | 2026年5月31日 | N-PORT |
| RECS · Columbia ETF Trust I | 0.00% | 8429 NS | 2026年4月30日 | N-PORT |
| MSLC · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 4089 NS | 2026年5月31日 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 9871 NS | 2026年4月30日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 1044 NS | 2026年4月30日 | N-PORT |
| GGUS · Goldman Sachs ETF Trust | 0.00% | 145 NS | 2026年5月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 1939 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 6609 NS | 2026年4月30日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VB · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VBK · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | — | — | 2026年7月15日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | — | — | 2026年7月15日 | 每日 |
| VONE · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VONV · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VONG · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 2026年7月15日 | 每日 |
| ITOT · iShares Trust | — | — | 2026年7月22日 | 每日 |
| IWS · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWP · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWR · iShares Trust | — | — | 2026年8月6日 | 每日 |
| IWV · iShares Trust | — | — | 2026年8月18日 | 每日 |
| IWD · iShares Trust | — | — | 2026年8月14日 | 每日 |
| IWF · iShares Trust | — | — | 2026年8月14日 | 每日 |
| IWB · iShares Trust | — | — | 2026年8月18日 | 每日 |
| SMMD · iShares Trust | — | — | 2026年8月18日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 2026年7月13日 | 每日 |
| VHT · VANGUARD WORLD FUND | — | — | 2026年7月20日 | 每日 |
| ESGV · VANGUARD WORLD FUND | — | — | 2026年7月30日 | 每日 |